Search bioRxiv⌕ Search

Biology subjects

Matveeva, T. V.

Publications and source records attributed to Matveeva, T. V..

2 recordsLinked to original sources

Study of the molecular nature of resistance to bifenazate in a Tetranychus urticae Koch Laboratory Strain

BACKGROUNDThe two-spotted spider mite, Tetranychus urticae Koch, is a major agricultural pest with a rapid propensity for developing acaricide resistance. Bifenazate targets mitochondrial cytochrome b (CYTB). While the G126S mutation is frequently associated with resistance, its independent role remains unclear as it often occurs with other substitutions. This study explores the molecular basis of bifenazate resistance in a Russian laboratory strain derived from a St. Petersburg greenhouse population. RESULTSDisruptive selection with increasing bifenazate concentrations generated resistant and susceptible isofemale lines. AlphaFold2 structural modeling of CYTB indicated that G126S causes a steric clash, leading to conformational destabilization, whereas other reported mutations primarily affect the ligand-binding pocket. Oxford Nanopore sequencing revealed a very low initial frequency of the G126S allele (<1%; 226/35,895 reads) in the unselected population. After one year of stepwise selection (0.00005-0.031% a.i.), the mutant allele frequency surged to 90% (7,272/8,056 reads). No other known resistance-associated mutations were found in the analyzed cytb fragment. CONCLUSIONWe report the first identification of the G126S mutation in a Russian T. urticae population and demonstrate its rapid fixation under bifenazate selection. Within this genetic background, G126S alone appears sufficient to confer high-level resistance, emphasizing the population-specific nature of resistance evolution and the critical need for local monitoring.

molecular biology↗

Development of a Bacterial Colorimetric Reporter System for Functional Screening of SARS-Cov-2 Main Protease Inhibitors Using Plant Preparations (juices): A Proof-of-Concept Study

SARS-CoV-2 main protease (Mpro) is essential for viral polyprotein processing and represents a prime target for antiviral drug discovery. However, most available screening strategies rely on biochemical and computational approaches that lack the biological context of living cells, or costly mammalian-cell based models. Therefore, there remains a shortage of simple and biosafe cellular models enabling rapid, functional screening of potential Mpro inhibitors, particularly those derived from natural sources and in urgent situations such as the COVID-19 pandemic. In this study, a bacterial colorimetric reporter system was developed that directly links SARS-CoV-2 Mpro activity to {beta}-galactosidase function in Escherichia coli. To the best of our knowledge, the developed system represents the first bacterial colorimetric model for direct monitoring of SARS-CoV-2 Mpro inhibition in living cells. The system enables real-time visual detection of protease inhibition on X-gal-containing medium and provides a cost-effective, biologically relevant, biosafe alternative to existing screening assays. Functional validation was performed using pomegranate juice as a representative natural inhibitor source. The system provides a simple, scalable, and biosafe platform for the primary screening of antiviral candidates, including phytochemicals, under standard laboratory conditions.

molecular biology↗